These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 14695823)

  • 1. Pyrrolobenzimidazoles linked to heterocycles and peptides. Design of DNA base pair specific phosphate hydrolyzing agents and novel cytotoxic agents.
    Ghodousi A; Huang X; Cheng Z; Skibo EB
    J Med Chem; 2004 Jan; 47(1):90-100. PubMed ID: 14695823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of pyrrolo[1,2-alpha]benzimidazolequinone DT-diaphorase substrate activity, topoisomerase II inhibition activity, and DNA reductive alkylation.
    Skibo EB; Gordon S; Bess L; Boruah R; Heileman MJ
    J Med Chem; 1997 Apr; 40(9):1327-39. PubMed ID: 9135030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of highly active analogues of the pyrrolo[1,2-a]benzimidazole antitumor agents.
    Craigo WA; LeSueur BW; Skibo EB
    J Med Chem; 1999 Aug; 42(17):3324-33. PubMed ID: 10464019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles.
    Atwell GJ; Fan JY; Tan K; Denny WA
    J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of C8-linked pyrrolo[2,1-c][1,4]benzodiazepine-benzimidazole conjugates with remarkable DNA-binding affinity.
    Kamal A; Ramulu P; Srinivas O; Ramesh G; Kumar PP
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4791-4. PubMed ID: 15324909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-H to N substitution dramatically alters the sequence-specific DNA alkylation, cytotoxicity, and expression of human cancer cell lines.
    Bando T; Narita A; Iwai A; Kihara K; Sugiyama H
    J Am Chem Soc; 2004 Mar; 126(11):3406-7. PubMed ID: 15025451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for DNA phosphate backbone alkylation and cleavage by pyrrolo[1,2-a]benzimidazoles: small molecules capable of causing base-pair-specific phosphodiester bond hydrolysis.
    Schulz WG; Nieman RA; Skibo EB
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11854-8. PubMed ID: 8524862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA alkylation by minor groove-binding N1-alkoxyalkyl-bis-benzimidazoles.
    Gupta R; Huang L; Wang H; Lown JW
    Anticancer Drug Des; 1995 Sep; 10(6):451-61. PubMed ID: 7575987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photocontrollable sequence-specific DNA alkylation by a pyrrole-imidazole polyamide seco-CBI conjugate.
    Park S; Bando T; Shinohara K; Nishijima S; Sugiyama H
    Bioconjug Chem; 2011 Feb; 22(2):120-4. PubMed ID: 21192678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners.
    Beria I; Baraldi PG; Cozzi P; Caldarelli M; Geroni C; Marchini S; Mongelli N; Romagnoli R
    J Med Chem; 2004 May; 47(10):2611-23. PubMed ID: 15115402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple molecular target approach to selective melanoma cytotoxicity.
    Skibo EB; Jamil A; Austin B; Hansen D; Ghodousi A
    Org Biomol Chem; 2010 Apr; 8(7):1577-87. PubMed ID: 20237668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA minor groove targeted alkylating agents based on bisbenzimidazole carriers: synthesis, cytotoxicity and sequence-specificity of DNA alkylation.
    Smaill JB; Fan JY; Denny WA
    Anticancer Drug Des; 1998 Dec; 13(8):857-80. PubMed ID: 10335264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry of the pyrrolo[1,2-alpha]benzimidazole antitumor agents: influence of the 7-substituent on the ability to alkylate DNA and inhibit topoisomerase II.
    Zhou R; Skibo EB
    J Med Chem; 1996 Oct; 39(21):4321-31. PubMed ID: 8863809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity studies of benzimidazole-based DNA-cleaving agents. Comparison of benzimidazole, pyrrolobenzimidazole, and tetrahydropyridobenzimidazole analogues.
    Skibo EB; Islam I; Heileman MJ; Schulz WG
    J Med Chem; 1994 Jan; 37(1):78-92. PubMed ID: 8289204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates.
    Jeffrey SC; Torgov MY; Andreyka JB; Boddington L; Cerveny CG; Denny WA; Gordon KA; Gustin D; Haugen J; Kline T; Nguyen MT; Senter PD
    J Med Chem; 2005 Mar; 48(5):1344-58. PubMed ID: 15743178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
    Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
    J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of pyrrolo[2,1-c][1,4]benzodiazepine and indole conjugates as anticancer agents.
    Wang JJ; Shen YK; Hu WP; Hsieh MC; Lin FL; Hsu MK; Hsu MH
    J Med Chem; 2006 Feb; 49(4):1442-9. PubMed ID: 16480280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of hybrid molecules containing alpha-methylene-gamma-butyrolactones and polypyrrole minor groove binders.
    Baraldi PG; Del Carmen Nunez M; Tabrizi MA; De Clercq E; Balzarini J; Bermejo J; Estévez F; Romagnoli R
    J Med Chem; 2004 May; 47(11):2877-86. PubMed ID: 15139766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 5,6-dihydropyrrolo[2,1-a]isoquinolines featuring an intramolecular radical-oxidative cyclization of polysubstituted pyrroles, and evaluation of their cytotoxic activity.
    Reyes-Gutiérrez PE; Camacho JR; Ramírez-Apan MT; Osornio YM; Martínez R
    Org Biomol Chem; 2010 Oct; 8(19):4374-82. PubMed ID: 20672155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid molecules between distamycin A and active moieties of antitumor agents.
    Baraldi PG; Preti D; Fruttarolo F; Tabrizi MA; Romagnoli R
    Bioorg Med Chem; 2007 Jan; 15(1):17-35. PubMed ID: 17081759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.